Transcriptomics Market by Technology (Microarray, Real-time PCR, and Sequencing Technology), Products & Services (Consumables, Instruments, Software, and Services), Application (Diagnostics & Disease Profiling, Drug Discovery, and Others), and End User (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, and Contract Research Organization) - Global Opportunity Analysis and Industry Forecast, 2017-2023
The Global Transcriptomics Market was valued at $3,130 million in 2016, and is projected to reach $4,658 million by 2023, growing at a CAGR of 5.8% during the study period. Transcriptomics is the study of entire set of RNA transcripts produced by the genome of any organism. Increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and rise in application of transcriptomics, which includes drug discovery is expected to drive the growth of the transcriptomics market. In addition, rise in funding and grants by various private and government organizations have further stimulated the market growth. However, certain drawbacks of RNA sequencing and lack of skilled professionals are expected to restrain the market growth.
Key Benefits
By Technology
Key Benefits
- The study provides an in-depth analysis of the global transcriptomics market, with current trends and future estimations to elucidate the imminent investment pockets.
- Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
By Technology
- Real Time-PCR (qPCR)
- Microarray
- Sequencing
- Sanger Sequencing
- RNA-Sequencing
- Consumables
- Instruments
- Software
- Services
- Diagnostics & Disease Profiling
- Drug Discovery
- Others
- Government Institutes & Academic Centers
- Pharmaceutical & Biotechnology Companies
- Contract research Organizations (CROs)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. TOP INVESTMENT POCKETS
3.3. MARKET SHARE ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Technological advancements in transcriptomics
3.4.1.2. Increase in applications of transcriptomics
3.4.1.3. Increase in research grants
3.4.1.4. Increase in genome mapping programs
3.4.2. Restraints
3.4.2.1. Standardization concerns over RNA sequencing
3.4.2.2. Lack of skilled professionals
3.4.3. Opportunity
3.4.3.1. Lucrative opportunities in emerging markets
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 TRANSCRIPTOMICS MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MICROARRAY
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION(Q-PCR)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. SEQUENCING TECHNOLOGIES
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Market size and forecast, by type
4.4.4.1. Sanger sequencing
4.4.4.1.1. Market size and forecast
4.4.4.2. RNA sequencing
4.4.4.2.1. Market size and forecast
CHAPTER 5 TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CONSUMABLES
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. INSTRUMENTS
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. SOFTWARE
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. SERVICES
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6 TRANSCRIPTOMICS MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. DIAGNOSTICS AND DISEASE PROFILING
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. DRUG DISCOVERY
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. OTHERS
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7 TRANSCRIPTOMICS MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. GOVERNMENT INSTITUTES AND ACADEMIC CENTERS
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. CONTRACT RESEARCH ORGANIZATION
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
CHAPTER 8 TRANSCRIPTOMICS MARKET, BY REGION
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends, growth factors and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. transcriptomics market
8.2.2.1.1. U.S. market size and forecast, by technology
8.2.2.1.2. U.S. market size and forecast, by products & services
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user
8.2.2.2. Canada transcriptomics market
8.2.2.2.1. Canada market size and forecast, by technology
8.2.2.2.2. Canada market size and forecast, by products & services
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user
8.2.2.3. Mexico transcriptomics market
8.2.2.3.1. Mexico market size and forecast, by technology
8.2.2.3.2. Mexico market size and forecast, by products & services
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user
8.2.3. North America market size and forecast, by technology
8.2.4. North America market size and forecast, by products & services
8.2.5. North America market size and forecast, by application
8.2.6. North America market size and forecast, by end user
8.3. EUROPE
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. Germany transcriptomics market
8.3.2.1.1. Germany market size and forecast, by technology
8.3.2.1.2. Germany market size and forecast, by products & services
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user
8.3.2.2. France transcriptomics market
8.3.2.2.1. France market size and forecast, by technology
8.3.2.2.2. France market size and forecast, by products & services
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user
8.3.2.3. UK transcriptomics market
8.3.2.3.1. UK market size and forecast, by technology
8.3.2.3.2. UK market size and forecast, by products & services
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user
8.3.2.4. Italy transcriptomics market
8.3.2.4.1. Italy market size and forecast, by technology
8.3.2.4.2. Italy market size and forecast, by products & services
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user
8.3.2.5. Spain transcriptomics market
8.3.2.5.1. Spain market size and forecast, by technology
8.3.2.5.2. Spain market size and forecast, by products & services
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user
8.3.2.6. Rest of Europe transcriptomics market
8.3.2.6.1. Rest of Europe market size and forecast, by technology
8.3.2.6.2. Rest of Europe market size and forecast, by products & services
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user
8.3.3. Europe market size and forecast, by technology
8.3.4. Europe market size and forecast, by products & services
8.3.5. Europe market size and forecast, by application
8.3.6. Europe market size and forecast, by end user
8.4. ASIA-PACIFIC
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. Japan transcriptomics market
8.4.2.1.1. Japan market size and forecast, by technology
8.4.2.1.2. Japan market size and forecast, by products & services
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user
8.4.2.2. China transcriptomics market
8.4.2.2.1. China market size and forecast, by technology
8.4.2.2.2. China market size and forecast, by products & services
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user
8.4.2.3. India transcriptomics market
8.4.2.3.1. India market size and forecast, by technology
8.4.2.3.2. India market size and forecast, by products & services
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user
8.4.2.4. Australia transcriptomics market
8.4.2.4.1. Australia market size and forecast, by technology
8.4.2.4.2. Australia market size and forecast, by products & services
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user
8.4.2.5. Rest of Asia-Pacific transcriptomics market
8.4.2.5.1. Rest of Asia-Pacific market size and forecast, by technology
8.4.2.5.2. Rest of Asia-Pacific market size and forecast, by products & services
8.4.2.5.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.5.4. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific market size and forecast, by technology
8.4.4. Asia-Pacific market size and forecast, by products & services
8.4.5. Asia-Pacific market size and forecast, by application
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. LAMEA market size and forecast, by country
8.5.2.1. Brazil transcriptomics market
8.5.2.1.1. Brazil market size and forecast, by technology
8.5.2.1.2. Brazil market size and forecast, by products & services
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user
8.5.2.2. South Africa transcriptomics market
8.5.2.2.1. South Africa market size and forecast, by technology
8.5.2.2.2. South Africa market size and forecast, by products & services
8.5.2.2.3. South Africa market size and forecast, by application
8.5.2.2.4. South Africa market size and forecast, by end user
8.5.2.3. Saudi Arabia transcriptomics market
8.5.2.3.1. Saudi Arabia market size and forecast, by technology
8.5.2.3.2. Saudi Arabia market size and forecast, by products & services
8.5.2.3.3. Saudi Arabia market size and forecast, by application
8.5.2.3.4. Saudi Arabia market size and forecast, by end user
8.5.2.4. Rest of LAMEA transcriptomics market
8.5.2.4.1. Rest of LAMEA market size and forecast, by technology
8.5.2.4.2. Rest of LAMEA market size and forecast, by products & services
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user
8.5.3. LAMEA market size and forecast, by technology
8.5.4. LAMEA market size and forecast, by products & services
8.5.5. LAMEA market size and forecast, by application
8.5.6. LAMEA market size and forecast, by end user
CHAPTER 9 COMPANY PROFILES
9.1. AGILENT TECHNOLOGIES INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.2. BIO-RAD LABORATORIES, INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.3. GENERAL ELECTRIC COMPANY
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. F. HOFFMANN-LA ROCHE LTD.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating product categories
9.4.4. Product portfolio
9.4.5. Business performance
9.5. FLUIDIGM CORPORATION
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. ILLUMINA, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.7. MERCK & CO., INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Merck: Product portfolio
9.7.5. Business performance
9.8. PROMEGA CORPORATION
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. QIAGEN N.V.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10. THERMO FISHER SCIENTIFIC INC
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. TOP INVESTMENT POCKETS
3.3. MARKET SHARE ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Technological advancements in transcriptomics
3.4.1.2. Increase in applications of transcriptomics
3.4.1.3. Increase in research grants
3.4.1.4. Increase in genome mapping programs
3.4.2. Restraints
3.4.2.1. Standardization concerns over RNA sequencing
3.4.2.2. Lack of skilled professionals
3.4.3. Opportunity
3.4.3.1. Lucrative opportunities in emerging markets
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 TRANSCRIPTOMICS MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MICROARRAY
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION(Q-PCR)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. SEQUENCING TECHNOLOGIES
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Market size and forecast, by type
4.4.4.1. Sanger sequencing
4.4.4.1.1. Market size and forecast
4.4.4.2. RNA sequencing
4.4.4.2.1. Market size and forecast
CHAPTER 5 TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CONSUMABLES
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. INSTRUMENTS
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. SOFTWARE
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. SERVICES
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6 TRANSCRIPTOMICS MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. DIAGNOSTICS AND DISEASE PROFILING
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. DRUG DISCOVERY
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. OTHERS
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7 TRANSCRIPTOMICS MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. GOVERNMENT INSTITUTES AND ACADEMIC CENTERS
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. CONTRACT RESEARCH ORGANIZATION
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
CHAPTER 8 TRANSCRIPTOMICS MARKET, BY REGION
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends, growth factors and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. transcriptomics market
8.2.2.1.1. U.S. market size and forecast, by technology
8.2.2.1.2. U.S. market size and forecast, by products & services
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user
8.2.2.2. Canada transcriptomics market
8.2.2.2.1. Canada market size and forecast, by technology
8.2.2.2.2. Canada market size and forecast, by products & services
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user
8.2.2.3. Mexico transcriptomics market
8.2.2.3.1. Mexico market size and forecast, by technology
8.2.2.3.2. Mexico market size and forecast, by products & services
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user
8.2.3. North America market size and forecast, by technology
8.2.4. North America market size and forecast, by products & services
8.2.5. North America market size and forecast, by application
8.2.6. North America market size and forecast, by end user
8.3. EUROPE
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. Germany transcriptomics market
8.3.2.1.1. Germany market size and forecast, by technology
8.3.2.1.2. Germany market size and forecast, by products & services
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user
8.3.2.2. France transcriptomics market
8.3.2.2.1. France market size and forecast, by technology
8.3.2.2.2. France market size and forecast, by products & services
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user
8.3.2.3. UK transcriptomics market
8.3.2.3.1. UK market size and forecast, by technology
8.3.2.3.2. UK market size and forecast, by products & services
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user
8.3.2.4. Italy transcriptomics market
8.3.2.4.1. Italy market size and forecast, by technology
8.3.2.4.2. Italy market size and forecast, by products & services
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user
8.3.2.5. Spain transcriptomics market
8.3.2.5.1. Spain market size and forecast, by technology
8.3.2.5.2. Spain market size and forecast, by products & services
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user
8.3.2.6. Rest of Europe transcriptomics market
8.3.2.6.1. Rest of Europe market size and forecast, by technology
8.3.2.6.2. Rest of Europe market size and forecast, by products & services
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user
8.3.3. Europe market size and forecast, by technology
8.3.4. Europe market size and forecast, by products & services
8.3.5. Europe market size and forecast, by application
8.3.6. Europe market size and forecast, by end user
8.4. ASIA-PACIFIC
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. Japan transcriptomics market
8.4.2.1.1. Japan market size and forecast, by technology
8.4.2.1.2. Japan market size and forecast, by products & services
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user
8.4.2.2. China transcriptomics market
8.4.2.2.1. China market size and forecast, by technology
8.4.2.2.2. China market size and forecast, by products & services
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user
8.4.2.3. India transcriptomics market
8.4.2.3.1. India market size and forecast, by technology
8.4.2.3.2. India market size and forecast, by products & services
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user
8.4.2.4. Australia transcriptomics market
8.4.2.4.1. Australia market size and forecast, by technology
8.4.2.4.2. Australia market size and forecast, by products & services
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user
8.4.2.5. Rest of Asia-Pacific transcriptomics market
8.4.2.5.1. Rest of Asia-Pacific market size and forecast, by technology
8.4.2.5.2. Rest of Asia-Pacific market size and forecast, by products & services
8.4.2.5.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.5.4. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific market size and forecast, by technology
8.4.4. Asia-Pacific market size and forecast, by products & services
8.4.5. Asia-Pacific market size and forecast, by application
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. LAMEA market size and forecast, by country
8.5.2.1. Brazil transcriptomics market
8.5.2.1.1. Brazil market size and forecast, by technology
8.5.2.1.2. Brazil market size and forecast, by products & services
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user
8.5.2.2. South Africa transcriptomics market
8.5.2.2.1. South Africa market size and forecast, by technology
8.5.2.2.2. South Africa market size and forecast, by products & services
8.5.2.2.3. South Africa market size and forecast, by application
8.5.2.2.4. South Africa market size and forecast, by end user
8.5.2.3. Saudi Arabia transcriptomics market
8.5.2.3.1. Saudi Arabia market size and forecast, by technology
8.5.2.3.2. Saudi Arabia market size and forecast, by products & services
8.5.2.3.3. Saudi Arabia market size and forecast, by application
8.5.2.3.4. Saudi Arabia market size and forecast, by end user
8.5.2.4. Rest of LAMEA transcriptomics market
8.5.2.4.1. Rest of LAMEA market size and forecast, by technology
8.5.2.4.2. Rest of LAMEA market size and forecast, by products & services
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user
8.5.3. LAMEA market size and forecast, by technology
8.5.4. LAMEA market size and forecast, by products & services
8.5.5. LAMEA market size and forecast, by application
8.5.6. LAMEA market size and forecast, by end user
CHAPTER 9 COMPANY PROFILES
9.1. AGILENT TECHNOLOGIES INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.2. BIO-RAD LABORATORIES, INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.3. GENERAL ELECTRIC COMPANY
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. F. HOFFMANN-LA ROCHE LTD.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating product categories
9.4.4. Product portfolio
9.4.5. Business performance
9.5. FLUIDIGM CORPORATION
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. ILLUMINA, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.7. MERCK & CO., INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Merck: Product portfolio
9.7.5. Business performance
9.8. PROMEGA CORPORATION
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. QIAGEN N.V.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10. THERMO FISHER SCIENTIFIC INC
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
LIST OF TABLES
TABLE 1. GLOBAL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 2. MICROARRAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. Q-PCR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. COMPARISON BETWEEN RNA-SEQUENCING AND EXPRESSION MICROARRAYS
TABLE 7. GLOBAL TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 8. PRODUCTS FOR ENRICHMENT
TABLE 9. CONSUMBALES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NGS PLATFORMS AVAILABLE FOR RNA-SEQUENCING
TABLE 11. INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. SOFTWARE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 15. DIAGNOSTICS AND DISEASE PROFILING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. DRUG DISCOVERY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. OTHER APPLICATIONS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. GOVERNMENT INSTITUTES AND ACADEMIC CENTERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. TRANSCRIPTOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. U.S. TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 25. U.S. TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 26. U.S. TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. U.S. TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 28. CANADA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 29. CANADA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 30. CANADA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 31. CANADA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 32. MEXICO TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 33. MEXICO TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 34. MEXICO TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. MEXICO TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 40. EUROPE TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 41. GERMANY TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 42. GERMANY TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 43. GERMANY TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. GERMANY TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. FRANCE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 46. FRANCE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 47. FRANCE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 48. FRANCE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 49. UK TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 50. UK TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 51. UK TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. UK TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. ITALY TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 54. ITALY TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 55. ITALY TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 56. ITALY TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 57. SPAIN TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 58. SPAIN TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 59. SPAIN TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. SPAIN TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 61. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 62. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 63. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 65. EUROPE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 66. EUROPE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 67. EUROPE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 68. EUROPE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 70. JAPAN TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 71. JAPAN TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 72. JAPAN TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 73. JAPAN TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 74. CHINA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 75. CHINA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 76. CHINA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 77. CHINA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 78. INDIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 79. INDIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 80. INDIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 81. INDIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 82. AUSTRALIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 83. AUSTRALIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 84. AUSTRALIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85. AUSTRALIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 86. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 90. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 91. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 92. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 93. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 94. LAMEATRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 95. BRAZIL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 96. BRAZIL TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 97. BRAZIL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 98. BRAZIL TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 99. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 100. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 101. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 102. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 103. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 104. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 105. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 106. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 107. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 108. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 109. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 110. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 111. LAMEA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 112. LAMEA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 113. LAMEA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 114. LAMEA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 115. AGILENT: COMPANY SNAPSHOT
TABLE 116. AGILENT: OPERATING SEGMENTS
TABLE 117. AGILENT: PRODUCT PORTFOLIO
TABLE 118. BIO-RAD: COMPANY SNAPSHOT
TABLE 119. BIO-RAD: OPERATING SEGMENTS
TABLE 120. BIO-RAD: PRODUCT PORTFOLIO
TABLE 121. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 122. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 123. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 124. ROCHE: COMPANY SNAPSHOT
TABLE 125. ROCHE: PRODUCT CATEGORIES
TABLE 126. ROCHE: PRODUCT PORTFOLIO
TABLE 127. FLUIDIGM: COMPANY SNAPSHOT
TABLE 128. FLUIDIGM: OPERATING SEGMENTS
TABLE 129. FLUIDIGM: PRODUCT PORTFOLIO
TABLE 130. ILLUMINA: COMPANY SNAPSHOT
TABLE 131. ILLUMINA: OPERATING SEGMENTS
TABLE 132. ILLUMINA: PRODUCT PORTFOLIO
TABLE 133. MERCK: COMPANY SNAPSHOT
TABLE 134. MERCK: OPERATING SEGMENTS
TABLE 135. MERCK: PRODUCT PORTFOLIO
TABLE 136. PROMEGA: COMPANY SNAPSHOT
TABLE 137. PROMEGA: PRODUCT CATEGORIES
TABLE 138. PROMEGA: PRODUCT PORTFOLIO
TABLE 139. QIAGEN: COMPANY SNAPSHOT
TABLE 140. QIAGEN: OPERATING SEGMENTS
TABLE 141. QIAGEN: PRODUCT PORTFOLIO
TABLE 142. THERMO FISHER: COMPANY SNAPSHOT
TABLE 143. THERMO FISHER: OPERATING SEGMENTS
TABLE 144. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 1. GLOBAL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 2. MICROARRAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. Q-PCR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL SEQUENCING TECHNOLOGIES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. COMPARISON BETWEEN RNA-SEQUENCING AND EXPRESSION MICROARRAYS
TABLE 7. GLOBAL TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 8. PRODUCTS FOR ENRICHMENT
TABLE 9. CONSUMBALES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NGS PLATFORMS AVAILABLE FOR RNA-SEQUENCING
TABLE 11. INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. SOFTWARE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 15. DIAGNOSTICS AND DISEASE PROFILING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. DRUG DISCOVERY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. OTHER APPLICATIONS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. GOVERNMENT INSTITUTES AND ACADEMIC CENTERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. TRANSCRIPTOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. U.S. TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 25. U.S. TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 26. U.S. TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. U.S. TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 28. CANADA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 29. CANADA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 30. CANADA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 31. CANADA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 32. MEXICO TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 33. MEXICO TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 34. MEXICO TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. MEXICO TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39. NORTH AMERICA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 40. EUROPE TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 41. GERMANY TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 42. GERMANY TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 43. GERMANY TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. GERMANY TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. FRANCE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 46. FRANCE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 47. FRANCE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 48. FRANCE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 49. UK TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 50. UK TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 51. UK TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. UK TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. ITALY TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 54. ITALY TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 55. ITALY TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 56. ITALY TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 57. SPAIN TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 58. SPAIN TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 59. SPAIN TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. SPAIN TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 61. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 62. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 63. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64. REST OF EUROPE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 65. EUROPE TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 66. EUROPE TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 67. EUROPE TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 68. EUROPE TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 70. JAPAN TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 71. JAPAN TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 72. JAPAN TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 73. JAPAN TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 74. CHINA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 75. CHINA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 76. CHINA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 77. CHINA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 78. INDIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 79. INDIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 80. INDIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 81. INDIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 82. AUSTRALIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 83. AUSTRALIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 84. AUSTRALIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85. AUSTRALIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 86. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 90. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 91. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 92. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 93. ASIA-PACIFIC TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 94. LAMEATRANSCRIPTOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 95. BRAZIL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 96. BRAZIL TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 97. BRAZIL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 98. BRAZIL TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 99. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 100. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 101. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 102. SOUTH AFRICA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 103. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 104. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 105. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 106. SAUDI ARABIA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 107. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 108. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 109. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 110. REST OF LAMEA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 111. LAMEA TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 112. LAMEA TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 113. LAMEA TRANSCRIPTOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 114. LAMEA TRANSCRIPTOMICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 115. AGILENT: COMPANY SNAPSHOT
TABLE 116. AGILENT: OPERATING SEGMENTS
TABLE 117. AGILENT: PRODUCT PORTFOLIO
TABLE 118. BIO-RAD: COMPANY SNAPSHOT
TABLE 119. BIO-RAD: OPERATING SEGMENTS
TABLE 120. BIO-RAD: PRODUCT PORTFOLIO
TABLE 121. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 122. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 123. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 124. ROCHE: COMPANY SNAPSHOT
TABLE 125. ROCHE: PRODUCT CATEGORIES
TABLE 126. ROCHE: PRODUCT PORTFOLIO
TABLE 127. FLUIDIGM: COMPANY SNAPSHOT
TABLE 128. FLUIDIGM: OPERATING SEGMENTS
TABLE 129. FLUIDIGM: PRODUCT PORTFOLIO
TABLE 130. ILLUMINA: COMPANY SNAPSHOT
TABLE 131. ILLUMINA: OPERATING SEGMENTS
TABLE 132. ILLUMINA: PRODUCT PORTFOLIO
TABLE 133. MERCK: COMPANY SNAPSHOT
TABLE 134. MERCK: OPERATING SEGMENTS
TABLE 135. MERCK: PRODUCT PORTFOLIO
TABLE 136. PROMEGA: COMPANY SNAPSHOT
TABLE 137. PROMEGA: PRODUCT CATEGORIES
TABLE 138. PROMEGA: PRODUCT PORTFOLIO
TABLE 139. QIAGEN: COMPANY SNAPSHOT
TABLE 140. QIAGEN: OPERATING SEGMENTS
TABLE 141. QIAGEN: PRODUCT PORTFOLIO
TABLE 142. THERMO FISHER: COMPANY SNAPSHOT
TABLE 143. THERMO FISHER: OPERATING SEGMENTS
TABLE 144. THERMO FISHER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. TRANSCRIPTOMICS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS, 2016
FIGURE 3. MARKET SHARE ANALYSIS, 2016
FIGURE 4. IMPACT ANALYSIS, 2016
FIGURE 6. TRANSCRIPTOMICS CLINICAL TRIALS, BY PHASE
FIGURE 7. COMPARATIVE ANALYSIS OF MICROARRAY MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 8. COMPARATIVE ANALYSIS OF Q- PCR MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 9. COMPARATIVE ANALYSIS OF SEQUENCING TECHNOLOGIES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 10. SANGER SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 11. RNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF CONSUMABLES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 13. COMPARATIVE ANALYSIS OF INSTRUMENTS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF SOFTWARE MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF SERVICES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF DIAGNOSTICS AND DISEASE PROFILING MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF DRUG DISCOVERY MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF GOVERNMENT INSTITUTES AND ACADEMIC CENTERS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 22. AGILENT: NET SALES, 2014-2016 ($MILLION)
FIGURE 23. AGILENT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 24. AGILENT: REVENUE BY REGION, 2016 (%)
FIGURE 25. BIO-RAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 26. BIO-RAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 27. BIO-RAD: REVENUE, BY REGION, 2016 (%)
FIGURE 28. GE HEALTHCARE: NET SALES, 2014-2016($MILLION)
FIGURE 29. GE HEALTHCARE: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 30. GE HEALTHCARE: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 31. ROCHE: NET-SALES, 2014-2016 ($MILLION)
FIGURE 32. ROCHE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 33. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34. FLUIDIGM: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. FLUIDIGM: REVENUE BY SEGMENT, 2016 (%)
FIGURE 36. FLUIDIGM: REVENUE BY REGION, 2016 (%)
FIGURE 37. ILLUMINA: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. ILLUMINA: REVENUE BY REGION, 2016 (%)
FIGURE 39. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. MERCK: REVENUE BY REGION, 2016 (%)
FIGURE 42. QIAGEN: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. QIAGEN: REVENUE BY PRODUCTS, 2016 (%)
FIGURE 44. QIAGEN: REVENUE BY REGION, 2016 (%)
FIGURE 45. THERMO FISHER: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. THERMO FISHER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. THERMO FISHER: REVENUE BY REGION, 2016 (%)
FIGURE 1. TRANSCRIPTOMICS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS, 2016
FIGURE 3. MARKET SHARE ANALYSIS, 2016
FIGURE 4. IMPACT ANALYSIS, 2016
FIGURE 6. TRANSCRIPTOMICS CLINICAL TRIALS, BY PHASE
FIGURE 7. COMPARATIVE ANALYSIS OF MICROARRAY MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 8. COMPARATIVE ANALYSIS OF Q- PCR MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 9. COMPARATIVE ANALYSIS OF SEQUENCING TECHNOLOGIES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 10. SANGER SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 11. RNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF CONSUMABLES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 13. COMPARATIVE ANALYSIS OF INSTRUMENTS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF SOFTWARE MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF SERVICES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF DIAGNOSTICS AND DISEASE PROFILING MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF DRUG DISCOVERY MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF GOVERNMENT INSTITUTES AND ACADEMIC CENTERS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 22. AGILENT: NET SALES, 2014-2016 ($MILLION)
FIGURE 23. AGILENT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 24. AGILENT: REVENUE BY REGION, 2016 (%)
FIGURE 25. BIO-RAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 26. BIO-RAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 27. BIO-RAD: REVENUE, BY REGION, 2016 (%)
FIGURE 28. GE HEALTHCARE: NET SALES, 2014-2016($MILLION)
FIGURE 29. GE HEALTHCARE: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 30. GE HEALTHCARE: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 31. ROCHE: NET-SALES, 2014-2016 ($MILLION)
FIGURE 32. ROCHE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 33. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34. FLUIDIGM: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. FLUIDIGM: REVENUE BY SEGMENT, 2016 (%)
FIGURE 36. FLUIDIGM: REVENUE BY REGION, 2016 (%)
FIGURE 37. ILLUMINA: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. ILLUMINA: REVENUE BY REGION, 2016 (%)
FIGURE 39. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. MERCK: REVENUE BY REGION, 2016 (%)
FIGURE 42. QIAGEN: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. QIAGEN: REVENUE BY PRODUCTS, 2016 (%)
FIGURE 44. QIAGEN: REVENUE BY REGION, 2016 (%)
FIGURE 45. THERMO FISHER: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. THERMO FISHER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. THERMO FISHER: REVENUE BY REGION, 2016 (%)
